Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hilton Hotels Corporation Common Stock (HLT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Hilton Hotels Corporation Common StockTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Hilton Hotels Corporation Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? Hilton Hotels Corporation Common Stock trades at $324.01 (market cap $70.82B), while Zimmer Biomet Holdings Inc trades at $96.52 (market cap $18.55B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 3.8× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (0.99%). Which is the better fit depends on your goals.

HLTZBH
Market Cap
$70.82B$18.55B
Sector
Consumer CyclicalHealth
52-Week High
$350.22$107.71
52-Week Low
$256.75$79.58
Enterprise Value
$83.83B$25.61B
Dividend Yield
0.19%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings (HLT) trades at $322.51, up 3.7% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains solid fundamentals with revenue growth to $12.04B in 2025 and net income of $1.46B. Recent news highlights labor strikes and executive stock sales, while analyst consensus remains bullish with a $352 price target.

HLT offers growth potential from travel recovery and pipeline expansion, but faces risks from premium valuation (P/E 46.21), rising debt levels, and operational challenges. The stock trades near resistance at $316-$319, requiring strong Q3 earnings to sustain momentum amid mixed technical indicators.

Zimmer Biomet Holdings Inc

ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.

The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.

Returns comparison

Trailing returns across standard periods

About Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.

Read more on HLT

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH